abs167.txt	background		compared	to	non-hispanic	whites		hispanic	women	are	more	likely	toreport	pain		depression		and	other	mental	health	concerns		however		little	isknown	about	hispanic	women's	use	of	supportive	medications		and	whether	usediffers	depending	on	nativity	(us-	vs		foreign-born)		this	study's	objectiveswere	to	examine	patterns	of	supportive	medication	use	and	investigate	potentialdifferences	by	ethnicity/nativity	among	women	with	breast	cancer	methods		we	used	the	surveillance		epidemiology		and	end	results	data	linked	withmedicare	claims	to	identify	women	diagnosed	with	incident	breast	cancer	betweenjuly	1		2007		and	december	31		2011		supportive	medication	use	(opioid	pain	andnon-opioid	psychotropic	medications)	in	the	90	days	after	diagnosis	was	theprimary	outcome		we	categorized	ethnicity/nativity	as	us-born	non-hispanic	us-born	hispanic		foreign-born	non-hispanic		and	foreign-born	hispanic		modifiedpoisson	models	examined	associations	between	ethnicity/nativity	and	medicationuse		adjusting	for	tumor		treatment		and	demographic	characteristics	results		we	included	23	091	women		of	whom	88%	were	us-born	non-hispanics		4%us-born	hispanics		6%	foreign-born	non-hispanics		and	2%	foreign-born	hispanics	supportive	medication	use	varied	by	ethnicity/nativity		compared	to	us-bornnon-hispanics		foreign-born	hispanics	and	non-hispanics	were	5%	(95%	ci0	92-0	98)	and	10%	(95%	ci	0	85-0	96)	less	likely	to	receive	supportivemedications		respectively		us-born	hispanics	were	5%	(95%	ci	1	02-1	09)	morelikely	to	receive	supportive	medications		observed	differences	persisted	whenanalyses	were	limited	to	stage	i-iii	breast	cancer	cases	conclusions		this	work	highlights	potential	disparities	in	the	pharmacologictreatment	of	psychosocial	needs	of	foreign-born	breast	cancer	patients		futurestudies	should	explore	if	differences	observed	here	are	reflective	of	healthdisparities	or	differential	patient	preferences	
